163 related articles for article (PubMed ID: 15892236)
1. Changes to oxfendazole chiral kinetics and anthelmintic efficacy induced by piperonyl butoxide in horses.
Sánchez Bruni SF; Fusé LA; Moreno L; Saumell CA; Alvarez LI; Fiel C; McKellar QA; Lanusse CE
Equine Vet J; 2005 May; 37(3):257-62. PubMed ID: 15892236
[TBL] [Abstract][Full Text] [Related]
2. Plasma achiral and chiral pharmacokinetic behaviour of intravenous oxfendazole co-administered with piperonyl butoxide in sheep.
Sánchez S; Small J; Jones DG; McKellar QA
J Vet Pharmacol Ther; 2002 Feb; 25(1):7-13. PubMed ID: 11874521
[TBL] [Abstract][Full Text] [Related]
3. Fenbendazole pharmacokinetics, metabolism, and potentiation in horses.
McKellar QA; Gokbulut C; Muzandu K; Benchaoui H
Drug Metab Dispos; 2002 Nov; 30(11):1230-9. PubMed ID: 12386129
[TBL] [Abstract][Full Text] [Related]
4. Comparative plasma disposition of fenbendazole, oxfendazole and albendazole in dogs.
Gokbulut C; Bilgili A; Hanedan B; McKellar QA
Vet Parasitol; 2007 Sep; 148(3-4):279-87. PubMed ID: 17673370
[TBL] [Abstract][Full Text] [Related]
5. Study (1991 to 2001) of drug-resistant Population B small strongyles in critical tests in horses in Kentucky at the termination of a 40-year investigation.
Lyons ET; Tolliver SC; Collins SS
Parasitol Res; 2007 Aug; 101(3):689-701. PubMed ID: 17468973
[TBL] [Abstract][Full Text] [Related]
6. Comparative plasma disposition kinetics of albendazole, fenbendazole, oxfendazole and their metabolites in adult sheep.
Lanusse CE; Gascon LH; Prichard RK
J Vet Pharmacol Ther; 1995 Jun; 18(3):196-203. PubMed ID: 7674455
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic interaction between oxfendazole and triclabendazole: In vitro biotransformation and systemic exposure in sheep.
Viviani P; Lifschitz AL; Luque SE; Lloberas MM; Maté ML; Cardozo PA; Lanusse CE; Virkel GL
Exp Parasitol; 2019 Sep; 204():107718. PubMed ID: 31201779
[TBL] [Abstract][Full Text] [Related]
8. Effects of formulation concentration on intravenous pharmacokinetics, chirality and in vitro solubility of oxfendazole and its metabolites in sheep.
Sánchez Bruni SF; Jones DG; Small J; McKellar QA
J Vet Pharmacol Ther; 2005 Oct; 28(5):467-73. PubMed ID: 16207310
[TBL] [Abstract][Full Text] [Related]
9. Cyathostomin resistance to moxidectin and combinations of anthelmintics in Australian horses.
Abbas G; Ghafar A; Hurley J; Bauquier J; Beasley A; Wilkes EJA; Jacobson C; El-Hage C; Cudmore L; Carrigan P; Tennent-Brown B; Gauci CG; Nielsen MK; Hughes KJ; Beveridge I; Jabbar A
Parasit Vectors; 2021 Dec; 14(1):597. PubMed ID: 34863271
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of pharmacokinetic interactions between piperonyl butoxide and albendazole against gastrointestinal nematodiasis in goats.
Kumbhakar NK; Sanyal PK; Rawte D; Kumar D; Kerketta AE; Pal S
J Helminthol; 2016 Sep; 90(5):624-9. PubMed ID: 26566193
[TBL] [Abstract][Full Text] [Related]
11. The effect of an oil formulation on the systemic availability of oxfendazole.
Ali DN; Chick BF
Int J Parasitol; 1992 Jul; 22(4):541-3. PubMed ID: 1644532
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic assessment of the monepantel plus oxfendazole combined administration in dairy cows.
Ballent M; Viviani P; Imperiale F; Dominguez P; Halwachs S; Mahnke H; Honscha W; Lanusse C; Virkel G; Lifschitz A
J Vet Pharmacol Ther; 2018 Apr; 41(2):292-300. PubMed ID: 29139145
[TBL] [Abstract][Full Text] [Related]
13. Anthelmintic efficacy of single active and combination products against commonly occurring parasites in foals.
Morris LH; Colgan S; Leathwick DM; Nielsen MK
Vet Parasitol; 2019 Apr; 268():46-52. PubMed ID: 30981305
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cytochrome P450 activity enhances the systemic availability of triclabendazole metabolites in sheep.
Virkel G; Lifschitz A; Sallovitz J; Ballent M; Scarcella S; Lanusse C
J Vet Pharmacol Ther; 2009 Feb; 32(1):79-86. PubMed ID: 19161459
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of the anthelmintic activity of oxfendazole by parbendazole.
Hennessy DR; Lacey E; Prichard RK; Steel JW
J Vet Pharmacol Ther; 1985 Sep; 8(3):270-5. PubMed ID: 3840535
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent activity of albendazole against benzimidazole-resistant nematodes in sheep: relationship between pharmacokinetics and efficacy.
Moreno L; Echevarria F; Muñoz F; Alvarez L; Sanchez Bruni S; Lanusse C
Exp Parasitol; 2004; 106(3-4):150-7. PubMed ID: 15172222
[TBL] [Abstract][Full Text] [Related]
17. A high oxfendazole dose to control porcine cysticercosis: pharmacokinetics and tissue residue profiles.
Moreno L; Lopez-Urbina MT; Farias C; Domingue G; Donadeu M; Dungu B; García HH; Gomez-Puerta LA; Lanusse C; González AE
Food Chem Toxicol; 2012 Oct; 50(10):3819-25. PubMed ID: 22841955
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of ivermectin and oxfendazole against Taenia solium cysticercosis and other parasitoses in naturally infected pigs.
Mkupasi EM; Ngowi HA; Sikasunge CS; Leifsson PS; Johansen MV
Acta Trop; 2013 Oct; 128(1):48-53. PubMed ID: 23806569
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the larvicidal efficacies of moxidectin or a five-day regimen of fenbendazole in horses harboring cyathostomin populations resistant to the adulticidal dosage of fenbendazole.
Reinemeyer CR; Prado JC; Nielsen MK
Vet Parasitol; 2015 Nov; 214(1-2):100-7. PubMed ID: 26477278
[TBL] [Abstract][Full Text] [Related]
20. Resistant nematodes in cattle: Pharmaco-therapeutic assessment of the ivermectin- ricobendazole combination.
Canton C; Ceballos L; Fiel C; Moreno L; Domingo Yagüez P; Bernat G; Lanusse C; Alvarez L
Vet Parasitol; 2017 Jan; 234():40-48. PubMed ID: 28115181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
